Savara Inc Employee-related Liabilities, Current
Savara Inc (SVRA) had Employee-related Liabilities, Current of $3.71 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:EmployeeRelatedLiabilitiesCurrent · last filed 2026-08-11
- 2026-06-30: Employee-related Liabilities, Current $3.71M.
- 2026-03-31: Employee-related Liabilities, Current $1.17M.
- 2025-12-31: Employee-related Liabilities, Current $6.55M.
- 2025-09-30: Employee-related Liabilities, Current $3.92M.
| Period end | Employee-related Liabilities, Current | Employee-related Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $3.71M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $1.17M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $6.55M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $3.92M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $2.26M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $1.02M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $5.02M 10-K · filed 2026-03-13 | |
| 2024-09-30 | $2.84M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $1.83M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $757.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $4.05M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $2.18M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $1.40M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $603.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $2.37M 10-K · filed 2024-03-07 | |
| 2022-09-30 | $1.61M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $1.14M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $590.00K 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $2.53M 10-K · filed 2023-03-30 | |
| 2020-12-31 | $1.92M 10-K · filed 2022-03-30 | |
| 2017-03-31 | $2.27M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $718.00K 10-Q · filed 2017-05-09 | |
| 2016-09-30 | $901.00K 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $1.13M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $976.00K 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $1.43M 10-K · filed 2017-03-06 | |
| 2015-09-30 | $1.29M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $950.00K 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $799.00K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $1.44M 10-K · filed 2016-03-14 | |
| 2014-09-30 | $1.51M 10-Q · filed 2014-10-31 | |
| 2014-06-30 | $1.04M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $772.76K 10-Q · filed 2014-05-05 | |
| 2013-12-31 | $1.37M 10-K · filed 2015-03-24 | $1.37M 10-K · filed 2014-03-26 |
| 2013-09-30 | $1.03M 10-Q · filed 2013-11-04 | |
| 2013-06-30 | $799.06K 10-Q · filed 2013-08-05 | |
| 2013-03-31 | $555.07K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $445.35K 10-K · filed 2014-03-26 | |
| 2012-09-30 | $825.80K 10-Q · filed 2012-11-05 | |
| 2012-06-30 | $661.45K 10-Q · filed 2012-08-06 | |
| 2012-03-31 | $478.52K 10-Q · filed 2012-05-07 | |
| 2011-12-31 | $756.77K 10-K · filed 2013-03-19 | |
| 2011-09-30 | $675.72K 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $411.14K 10-Q · filed 2011-08-08 | |
| 2010-12-31 | $456.84K 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |